Filing Details

Accession Number:
0001127602-22-006985
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-02-28 14:40:31
Reporting Period:
2022-02-25
Accepted Time:
2022-02-28 14:40:31
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
794172 Meridian Bioscience Inc VIVO In Vitro & In Vivo Diagnostic Substances (2835) 310888197
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1795272 S. Andrew Kitzmiller 3471 River Hills Drive
Cincinnati OH 45244
Evp & Cfo No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-02-25 4,028 $24.87 11,528 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. The reported price is a weighted average price. These shares were purchased in multiple transactions ranging from $24.8251 to $24.8698. The Reporting Person undertakes to provide full pricing information if requested by the Securities and Exchange Commission, the issuer or a security holder of the issuer.